Quote For Novartis AG NOVN.VX
sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
As of
9:20am GMT
55.75CHF
CHF55.75
9:20am GMT
+0.27%
CHF55.60
CHF55.90
797,452
CHF55.95
CHF55.65
CHF58.30
CHF39.08
0.76
5,063,510
News
No news stories for this company within the last 30 days.
Press Releases
No news stories for this company within the last 30 days.
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Vasella, Daniel |
Chairman of the Board, Chief Executive Officer |
3,315,780 |
| Lehner, Ulrich |
Independent Non-Executive Vice Chairman of the Board, Lead Director |
1,050,000 |
| Rudloff, Hans-Joerg |
Non-Executive Vice Chairman of the Board, Independent Non-Executive Director |
736,337 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
CHF126,278.70 |
| Shares Outstanding (Mil.) |
2,271.20 |
| Float (Mil.) |
2,248.49 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (CHF CHF) |
2.02 |
| Payout Ratio(TTM) % |
56.56 |
| |
| Financial Strength |
| Quick Ratio |
0.91 |
| Current Ratio |
1.70 |
| LT Debt/Equity |
16.33 |
| Total Debt/Equity |
26.95 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
16.53 |
| Price/Sales(TTM) |
2.95 |
| Price/Book(TTM) |
2.34 |
| Price/Cash Flow(TTM) |
12.50 |
| |
|
| Per Share Data |
| Earnings(TTM) |
CHF3.39 |
| Sales(TTM) |
CHF18.75 |
| Book Value(MRQ) |
CHF23.74 |
| Cash Flow(TTM) |
CHF4.43 |
| Cash(MRQ) |
CHF-- |
|
| Management Effectiveness |
| Return on Equity(TTM) |
14.59 |
| Return on Assets(TTM) |
8.85 |
| Return on Investment(TTM) |
11.33 |
| |
|
| Margins |
| Gross Margin(TTM) % |
72.61 |
| Operating Margin(TTM) % |
21.33 |
| Profit Margin(TTM) % |
18.05 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives